| Overview |
| bsm-90061r-50µL |
| CD44 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human CD44 |
| 1-250/742 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 960 |
| P16070 |
| CD44 Molecule (Indian Blood Group); HUTCH-I; HCELL; CSPG8; MC56; Pgp1; MDU2; MDU3; MIC4; IN; Hematopoietic Cell E- And L-Selectin Ligand; GP90 Lymphocyte Homing/Adhesion Receptor; Chondroitin Sulfate Proteoglycan 8; Extracellular Matrix Receptor III; Homing Cell Adhesion Molecule; Heparan Sulfate Proteoglycan; Phagocytic Glycoprotein 1; Phagocyte Glycoprotein 1; Hyaluronate Receptor; In(Lu) Related-P80; Hermes Antigen; CD44 Antigen; Hermes-1; ECMR-III; HUTCH-1; ECM-III; Epican; PGP-1; CD44R; CDw44; H-CAM; LHR; CD44 Antigen (Homing Function And Indian Blood Group System); Homing Function And Indian Blood Group System; Extracellular Matrix Receptor-III; Cell Surface Glycoprotein CD44; Indian Blood Group Antigen; Phagocytic Glycoprotein I; Soluble CD44; CDW44; PGP-I |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |